Ademowo, O. G. und Sodeinde, O. (2002): Certain red cell genetic factors and prevalence of chloroquine-induced pruritus, Afr J Med Med Sci 31 [4], Seite 341-3. URL:

Adjuik, M.; Agnamey, P.; Babiker, A.; Borrmann, S.; Brasseur, P.; Cisse, M.; Cobelens, F.; Diallo, S.; Faucher, J. F.; Garner, P.; Gikunda, S.; Kremsner, P. G.; Krishna, S.; Lell, B.; Loolpapit, M.; Matsiegui, P. B.; Missinou, M. A.; Mwanza, J.; Ntoumi, F.; Olliaro, P.; Osimbo, P.; Rezbach, P.; Some, E. und Taylor, W. R. (2002): Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial, Lancet 359 [9315], Seite 1365-72. URL:

Afari, E. A.; Akanmori, B. D.; Nakano, T. und Ofori-Adjei, D. (1992): Plasmodium falciparum: sensitivity to chloroquine in vivo in three ecological zones in Ghana, Trans R Soc Trop Med Hyg 86 [3], Seite 231-2. URL:

Alrajhi, A. A. (1999): Possible establishment of chloroquine-resistant P. falciparum in Saudi Arabia, Am J Trop Med Hyg 60 [4], Seite 519-20. URL:

Babiker, H. A.; Lines, J.; Hill, W. G. und Walliker, D. (1997): Population structure of Plasmodium falciparum in villages with different malaria endemicity in east Africa, Am J Trop Med Hyg 56 [2], Seite 141-7. URL:

Babiker, H. A.; Pringle, S. J.; Abdel-Muhsin, A.; Mackinnon, M.; Hunt, P. und Walliker, D. (2001): High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1, J Infect Dis 183 [10], Seite 1535-8. URL:

Baird, J. K.; Owusu Agyei, S.; Utz, G. C.; Koram, K.; Barcus, M. J.; Jones, T. R.; Fryauff, D. J.; Binka, F. N.; Hoffman, S. L. und Nkrumah, F. N. (2002 ): Seasonal malaria attack rates in infants and young children in northern Ghana, Am J Trop Med Hyg 66 [3], Seite 280-6. URL:

Barat, L.; Chipipa, J.; Kolczak, M. und Sukwa, T. (1999): Does the availability of blood slide microscopy for malaria at health centers improve the management of persons with fever in Zambia ?, Am J Trop Med Hyg 60 [6], Seite 1024-30. URL:

Basco, L. K. und Ringwald, P. (2000): Molecular epidemiology of malaria in Yaounde, Cameroon. VII. Analysis of recrudescence and reinfection in patients with uncomplicated falciparum malaria, Am J Trop Med Hyg 63 [5-6], Seite 215-21. URL:

Basco, L. K. und Ringwald, P. (2001): Analysis of the key pfcrt point mutation and in vitro and in vivo response to chloroquine in Yaounde, Cameroon, J Infect Dis 183 [12], Seite 1828-31. URL:

Binka, F. N.; Morris, S. S.; Ross, D. A.; Arthur, P. und Aryeetey, M. E. (1994): Patterns of malaria morbidity and mortality in children in northern Ghana, Trans R Soc Trop Med Hyg 88 [4], Seite 381-5. URL:

Bjorkman, A. und Willcox, M. (1986): In vivo and in vitro susceptibility of Plasmodium falciparum to sulphadoxine/pyrimethamine in Liberia, West Africa, Trans R Soc Trop Med Hyg 80 [4], Seite 572-4. URL:

Bloland, P. B. und Ettling, M. (1999): Making malaria-treatment policy in the face of drug resistance, Ann Trop Med Parasitol 93 [1], Seite 5-23. URL:

Bloland, P. B.; Ettling, M. und Meek, S. (2000): Combination therapy for malaria in Africa: hype or hope ?, Bull World Health Organ 78 [12], Seite 1378-88. URL:

Bloland, P. B.; Lackritz, E. M.; Kazembe, P. N.; Were, J. B.; Steketee, R. und Campbell, C. C. (1993): Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa, J Infect Dis 167 [4], Seite 932-7. URL:

Bojang, K. A.; Schneider, G.; Forck, S.; Obaro, S. K.; Jaffar, S.; Pinder, M.; Rowley, J. und Greenwood, B. M. (1998): A trial of Fansidar plus chloroquine or Fansidar alone for the treatment of uncomplicated malaria in Gambian children, Trans R Soc Trop Med Hyg 92 [1], Seite 73-6. URL:

Bottius, E.; Guanzirolli, A.; Trape, J. F.; Rogier, C.; Konate, L. und Druilhe, P. (1996): Malaria: even more chronic in nature than previously thought; evidence for subpatent parasitaemia detectable by the polymerase chain reaction, Trans R Soc Trop Med Hyg 90 [1], Seite 15-9. URL:

Boyd, MF (1949): Historical Review, Boyd, Malariology 1 Seite 10, Saunders, Philadelphia.

Brabin, B. (1990): An analysis of malaria parasite rates in infants: 40 years after McDonald, Trop Dis Bull 87, Seite R1-R21.

Brasseur, P.; Kouamouo, J.; Brandicourt, O.; Moyou-Somo, R. und Druilhe, P. (1988): Patterns of in vitro resistance to chloroquine, quinine, and mefloquine of Plasmodium falciparum in Cameroon, 1985-1986, Am J Trop Med Hyg 39 [2], Seite 166-72. URL:

Breman, J. G. und Camp bell, C. C. (1988): Combating severe malaria in African children, Bull World Health Organ 66 [5], Seite 611-20. URL:

Brown, KN; Berzins, K; Jarra, W und Schetters, T (1986): Immune responses to erythrocytic malaria, Clin. Immunol. Allergy 6, Seite 227-249.

Browne, E. N.; Frimpong, E.; Sievertsen, J.; Hagen, J.; Hamelmann, C.; Dietz, K.; Horstmann, R. D. und Burchard, G. D. (2000): Malariometric update for the rainforest and savanna of Ashanti region, Ghana, Ann Trop Med Parasitol 94 [1], Seite 15-22. URL:

Bruce-Chwatt, LJ (1981): Chemotherapy of malaria, WHO, Geneva.

Campbell, C. C.; Chin, W.; Collins, W.E.; S.M., Teutsch und Moss, D. M. (1979): Chloroquine-resistant Plasmodium falciparum from East Africa: cultivation and drug sensitivity of the Tanzanian I/CDC strain from an American tourist, Lancet 2, Seite 1151-1154.

Checchi, F.; Piola, P.; Kosack, C.; Ardizzoni, E.; Klarkowski, D.; Kwezi, E.; Priotto, G.; Balkan, S.; Bakyaita, N.; Brockman, A. und Guthmann, J. P. (2004): Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda, Trop Med Int Health 9 [4], Seite 445-50. URL:

CIA (2004): CIA World Fact Book. URL:

De Cock, K. M. (1997): Guidelines for managing HIV infection, Bmj 315 [7099], Seite 1-2. URL:

Djimde, A.; Doumbo, O. K.; Cortese, J. F.; Kayentao, K.; Doumbo, S.; Diourte, Y.; Dicko, A.; Su, X. Z.; Nomura, T.; Fidock, D. A.; Wellems, T. E.; Plowe, C. V. und Coulibaly, D. (2001): A molecular marker for chloroquine-resistant falciparum malaria, N Engl J Med 344 [4], Seite 257-63. URL:

Doberstyn, E. B.; Hall, A. P.; Vetvutanapibul, K. und Sonkon, P. (1976): Single-dose therapy of Falciparum malaria using pyrimethamine in combination with diformyldapsone or sulfadoxine, Am J Trop Med Hyg 25 [1], Seite 14-9. URL:

Dorsey, G.; Njama, D.; Kamya, M. R.; Cattamanchi, A.; Kyabayinze, D.; Staedke, S. G.; Gasasira, A. und Rosenthal, P. J. (2002): Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial, Lancet 360 [9350], Seite 2031-8. URL:

Dorsey, G.; Vlahos, J.; Kamya, M. R.; Staedke, S. G. und Rosenthal, P. J. (2003): Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria, J Infect Dis 188 [8], Seite 1231-8. URL:

Driessen, G. J.; van Kerkhoven, S.; Schouwenberg, B. J.; Bonsu, G. und Verhave, J. P. (2002): Sulphadoxine/pyrimethamine: an appropriate first-line alternative for the treatment of uncomplicated falciparum malaria in Ghanaian children under 5 years of age, Trop Med Int Health 7 [7], Seite 577-83. URL:

Dzisi, S. Y. (2002): Childhood malaria in the Bulpeila Subdistrict of Tamale, Northern Ghana: A study on knowledge, perceptions and attitudes, and socio-demographic factors among care givers, Master of Science in International Health, Institute of Tropical Medicine, Humboldt University, Berlin.

EANMAT (2001): Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience, Trop Med Int Health 6 [11], Seite 891-8. URL:

Ehrhardt, S.; Mockenhaupt, F. P.; Agana-Nsiire, P.; Mathieu, A.; Anemana, S. D.; Stark, K.; Otchwemah, R. N. und Bienzle, U. (2002): Efficacy of chloroquine in the treatment of uncomplicated, Plasmodium falciparum malaria in northern Ghana, Ann Trop Med Parasitol 96 [3], Seite 239-47. URL:

Ehrhardt, S.; Mockenhaupt, F. P.; Eggelte, T. A.; Agana-Nsiire, P.; Stollberg, K.; Anemana, S. D.; Stark, K.; Otchwemah, R. N. und Bienzle, U. (2003): Chloroquine blood concentrations and molecular markers of chloroquine-resistant Plasmodium falciparum in febrile children in northern Ghana, Trans R Soc Trop Med Hyg 97, Seite 1-5.

Ettling, M. B. (2002): The control of malaria in Vietnam from 1980 to 2000: What went right?, Report of Consultancy for World Health Organization Regional Office for the Western Pacific, Manila, World Health Organization

Farmer, P. und Kim, J. Y. (1998): Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus", Bmj 317 [7159], Seite 671-4. URL:

Fidock, D. A.; Nomura, T.; Talley, A. K.; Cooper, R. A.; Dzekunov, S. M.; Ferdig, M. T.; Ursos, L. M.; Sidhu, A. B.; Naude, B.; Deitsch, K. W.; Su, X. Z.; Wootton, J. C.; Roepe, P. D. und Wellems, T. E. (2000): Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance, Mol Cell 6 [4], Seite 861-71. URL:

Fogh, S.; Jepsen, S. und Effersoe, P. (1979): Chloroquine-resistant Plasmodium falciparum malaria in Kenya, Trans R Soc Trop Med Hyg 73 [2], Seite 228-9. URL:

Foster, S. (1994): Economic prospects for a new antimalarial drug, Trans R Soc Trop Med Hyg 88 Suppl 1, Seite S55-6. URL:

Foster, S. D. (1991): Pricing, distribution, and use of antimalarial drugs, Bull World Health Organ 69 [3], Seite 349-63. URL:

Gasasira, A. F.; Dorsey, G.; Nzarubara, B.; Staedke, S. G.; Nassali, A.; Rosenthal, P. J. und Kamya, M. R. (2003): Comparative efficacy of aminoquinoline-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda, Am J Trop Med Hyg 68 [2], Seite 127-32. URL:

Gilles, H. M. (1991): Management of Severe and Complicated Malaria. A Practical Handbook, World Health Organization, Geneva.

Ginsburg, H.; Ward, S. A. und Bray, P. G. (1999): An integrated model of chloroquine action, Parasitol Today 15 [9], Seite 357-60. URL:

Githeko, A. K.; Brandling-Bennett, A. D.; Beier, M.; Atieli, F.; Owaga, M. und Collins, F. H. (1992): The reservoir of Plasmodium falciparum malaria in a holoendemic area of western Kenya, Trans R Soc Trop Med Hyg 86 [4], Seite 355-8. URL: ://

Gogtay, N. J.; Desai, S.; Kadam, V. S.; Kamtekar, K. D.; Dalvi, S. S. und Kshirsagar, N. A. (2000): A randomized, parallel-group study in Mumbai (Bombay), comparing chloroquine with chloroquine plus sulfadoxine-pyrimethamine in the treatment of adults with acute, uncomplicated, Plasmodium falciparum malaria, Ann Trop Med Parasitol 94 [4], Seite 309-12. URL:

Gorissen, E.; Ashruf, G.; Lamboo, M.; Bennebroek, J.; Gikunda, S.; Mbaruku, G. und Kager, P. A. (2000): In vivo efficacy study of amodiaquine and sulfadoxine/ pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania, Trop Med Int Health 5 [6], Seite 459-63. URL:

Greenwood, B. M. (1987): Asymptomatic malaria infections - Do they matter?, Parasitol Today 3 [7], Seite 206-14. URL:

Greenwood, B. M.; Bradley, A. K.; Greenwood, A. M.; Byass, P.; Jammeh, K.; Marsh, K.; Tulloch, S.; Oldfield, F. S. und Hayes, R. (1987): Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa, Trans R Soc Trop Med Hyg 81 [3], Seite 478-86. URL:

Hastings, I. M. und Mackinnon, M. J. (1998): The emergence of drug-resistant malaria, Parasitology 117 ( Pt 5), Seite 411-7. URL:

Hogh, B.; Marbiah, N. T.; Burghaus, P. A. und Andersen, P. K. (1995): Relationship between maternally derived anti-Plasmodium falciparum antibodies and risk of infection and disease in infants living in an area of Liberia, west Africa, in which malaria is highly endemic, Infect Immun 63 [10], Seite 4034-8. URL:

Hugosson, E.; Tarimo, D.; Troye-Blomberg, M.; Montgomery, S. M.; Premji, Z. und Bjorkman, A. (2003): Antipyretic, parasitologic, and immunologic effects of combining sulfadoxine/pyrimethamine with chloroquine or paracetamol for treating uncomplicated Plasmodium falciparum malaria, Am J Trop Med Hyg 69 [4], Seite 366-71. URL:

Iyer, J. K.; Milhous, W. K.; Cortese, J. F.; Kublin, J. G. und Plowe, C. V. (2001): Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine, Lancet 358 [9287], Seite 1066-7. URL:

Jelinek, T.; Kilian, A. H.; Curtis, J.; Duraisingh, M. T.; Kabagambe, G.; von Sonnenburg, F. und Warhurst, D. C. (1999): Plasmodium falciparum: selection of serine 108 of dihydrofolate reductase during treatment of uncomplicated malaria with co-trimoxazole in Ugandan children, Am J Trop Med Hyg 61 [1], Seite 125-30. URL:

Jonkman, A.; Chibwe, R. A.; Khoromana, C. O.; Liabunya, U. L.; Chaponda, M. E.; Kandiero, G. E.; Molyneux, M. E. und Taylor, T. E. (1995): Cost-saving through microscopy-based versus presumptive diagnosis of malaria in adult outpatients in Malawi, Bull World Health Organ 73 [2], Seite 223-7. URL:

Kazadi, W. M.; Vong, S.; Makina, B. N.; Mantshumba, J. C.; Kabuya, W.; Kebela, B. I. und Ngimbi, N. P. (2003): Assessing the efficacy of chloroquine and sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in the Democratic Republic of Congo, Trop Med Int Health 8 [10], Seite 868-75. URL:

Keuter, M.; Sanders, J.; Ronday, M.; Veltkamp, S.; Kamsteeg, H.; Schouten, E.; Khalumi, G.; Ngwawe, W.; Wetsteyn, J. C. und Brandling-Bennett, A. D. (1992): Parasitological, clinical and haematological response of children with Plasmodium falciparum to 4-aminoquinolines and to pyrimethamine-sulfadoxine with quinine in western Kenya, Trop Geogr Med 44 [1-2], Seite 1-8. URL:

Kitua, A. Y. (1999): Antimalarial drug policy: making systematic change, Lancet 354 Suppl, Seite SIV32. URL:

Kofoed, P. E.; Alfrangis, M.; Poulsen, A.; Rodrigues, A.; Gjedde, S. B.; Ronn, A. und Rombo, L. (2004): Genetic markers of resistance to pyrimethamine and sulfonamides in Plasmodium falciparum parasites compared with the resistance patterns in isolates of Escherichia coli from the same children in Guinea-Bissau, Trop Med Int Health 9 [1], Seite 171-7. URL:

Koram, K. A.; Owusu-Agyei, S.; Utz, G.; Binka, F. N.; Baird, J. K.; Hoffman, S. L. und Nkrumah, F. K. (2000): Severe anemia in young children after high and low malaria transmission seasons in the Kassena-Nankana district of northern Ghana, Am J Trop Med Hyg 62 [6], Seite 670-4. URL:

Kremsner, P. G.; Zotter, G. M.; Feldmeier, H.; Bienzle, U.; Jansen-Rosseck, R.; Graninger, W.; Rocha, R. M. und Wernsdorfer, W. H. (1989): Differences in drug response of Plasmodium falciparum within an area of the Amazon region, Trans R Soc Trop Med Hyg 83 [2], Seite 158-61. URL:

Krishna, S. und White, N. J. (1996): Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications, Clin Pharmacokinet 30 [4], Seite 263-99. URL:

Kublin, J. G.; Cortese, J. F.; Njunju, E. M.; Mukadam, R. A.; Wirima, J. J.; Kazembe, P. N.; Djimde, A. A.; Kouriba, B.; Taylor, T. E. und Plowe, C. V. (2003): Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi, J Infect Dis 187 [12], Seite 1870-5. URL:

Landau, I.; Lepers, J. P.; Ringwald, P.; Rabarison, P.; Ginsburg, H. und Chabaud, A. (1992): Chronotherapy of malaria: improved efficacy of timed chloroquine treatment of patients with Plasmodium falciparum infections, Trans R Soc Trop Med Hyg 86 [4], Seite 374-5. URL:

Landgraf, B.; Kollaritsch, H.; Wiedermann, G. und Wernsdorfer, W. H. (1994): Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren, Trans R Soc Trop Med Hyg 88 [4], Seite 440-2. URL:

Looareesuwan, S.; Harinasuta, T. und Chongsuphajaisiddhi, T. (1992): Drug resistant malaria, with special reference to Thailand, Southeast Asian J Trop Med Public Health 23 [4], Seite 621-34. URL:

Mackinnon, M. J. (1997): Survival probability of drug resistant mutants in malaria parasites, Proc R Soc Lond B Biol Sci 264 [1378], Seite 53-9. URL:

Mackinnon, M. J. und Hastings, I. M. (1998): The evolution of multiple drug resistance in malaria parasites, Trans R Soc Trop Med Hyg 92 [2], Seite 188-95. URL:

Marsh, K. (1992): Malaria--a neglected disease ?, Parasitology 104 Suppl, Seite S53-69. URL: ://

Marsh, K.; Otoo, L.; Hayes, R. J.; Carson, D. C. und Greenwood, B. M. (1989): Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection, Trans R Soc Trop Med Hyg 83 [3], Seite 293-303. URL:

Mavrikakis, M.; Papazoglou, S.; Sfikakis, P. P.; Vaiopoulos, G. und Rougas, K. (1996): Retinal toxicity in long term hydroxychloroquine treatment, Ann Rheum Dis 55 [3], Seite 187-9. URL:

May, J.; Mockenhaupt, F. P.; Ademowo, O. G.; Falusi, A. G.; Olumese, P. E.; Bienzle, U. und Meyer, C. G. (1999): High rate of mixed and subpatent malarial infections in southwest Nigeria, Am J Trop Med Hyg 61 [2], Seite 339-43. URL:

Mberu, E. K.; Mosobo, M. K.; Nzila, A. M.; Kokwaro, G. O.; Sibley, C. H. und Watkins, W. M. (2000): The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya, Am J Trop Med Hyg 62 [3], Seite 396-401. URL:

McCombie, S. C. (1996): Treatment seeking for malaria: a review of recent research, Soc Sci Med 43 [6], Seite 933-45. URL:

McFayden, J. E. (1999): International drug price indicator guide, Management Sciences for Health, Arlington, VA.

McGregor, I. A. (1984): Epidemiology, malaria and pregnancy, Am J Trop Med Hyg 33 [4], Seite 517-25. URL:

McIntosh, H. M. (2001): Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria, Cochrane Database Syst Rev [4], Seite CD000386. URL:

Menendez, C.; Kahigwa, E.; Hirt, R.; Vounatsou, P.; Aponte, J. J.; Font, F.; Acosta, C. J.; Schellenberg, D. M.; Galindo, C. M.; Kimario, J.; Urassa, H.; Brabin, B.; Smith, T. A.; Kitua, A. Y.; Tanner, M. und Alonso, P. L. (1997): Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants, Lancet 350 [9081], Seite 844-50. URL:

Miller, K. D.; Lobel, H. O.; Satriale, R. F.; Kuritsky, J. N.; Stern, R. und Campbell, C. C. (1986): Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis, Am J Trop Med Hyg 35 [3], Seite 451-8. URL: ://

Ministry of Health, Ghana (2000): Annual report on Maternal and Child Health, September

Mockenhaupt, F. P.; Eggelte, T. A.; Bohme, T.; Thompson, W. N. und Bienzle, U. (2001): Plasmodium falciparum dihydrofolate reductase alleles and pyrimethamine use in pregnant Ghanaian women, Am J Trop Med Hyg 65 [1], Seite 21-6. URL:

Mockenhaupt, F. P.; May, J.; Bergqvist, Y.; Ademowo, O. G.; Olumese, P. E.; Falusi, A. G.; Grossterlinden, L.; Meyer, C. G. und Bienzle, U. (2000): Concentrations of chloroquine and malaria parasites in blood in Nigerian children, Antimicrob Agents Chemother 44 [4], Seite 835-9. URL:

Mockenhaupt, F. P.; May, J.; Bienzle, U. und Meyer, C. G. (1997): [Drug-resistant malaria], Dtsch Med Wochenschr 122 [42], Seite 1293-7. URL:

Mockenhaupt, F. P.; Thies, F. L. und Meyer, C. G. (1998): Malaria im Kindesalter, Pädiatrische Praxis 55, Seite 305-318.

Moore, D. V. und Lanier, J. E. (1961): Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine, Am J Trop Med Hyg 10, Seite 5-9. URL:

Muehlen, M.; Schreiber, J.; Ehrhardt, S.; Otchwemah, R.; Jelinek, T.; Bienzle, U. und Mockenhaupt, F. P. (2004): Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana, Trop Med Int Health 9 [3], Seite 361-3. URL:

Muller, O.; van Hensbroek, M. B.; Jaffar, S.; Drakeley, C.; Okorie, C.; Joof, D.; Pinder, M. und Greenwood, B. (1996): A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria, Trop Med Int Health 1 [1], Seite 124-32. URL:

Mutabingwa, T.; Nzila, A.; Mberu, E.; Nduati, E.; Winstanley, P.; Hills, E. und Watkins, W. (2001 ): Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania, Lancet 358 [9289], Seite 1218-23. URL:

Neequaye, J. (1986): In vivo chloroquine-resistant falciparum malaria in western Africa, Lancet, Seite 153.

Neequaye, J.; Ofori-Adjei, D.; Odame, I.; Coker, L. und Mensah-Annan (1988): Falciparum malaria not sensitive to chloroquine emerges in Accra in 1987, Ghana Medical Journal 22, Seite 6-10.

Nosten, F.; Hien, T. T. und White, N. J. (1998): Use of artemisinin derivatives for the control of malaria, Med Trop (Mars) 58 [3 Suppl], Seite 45-9. URL:

Nwanyanwu, O. C.; Redd, S. C.; Ziba, C.; Luby, S. P.; Mount, D. L.; Franco, C.; Nyasulu, Y. und Chitsulo, L. (1996): Validity of mother's history regarding antimalarial drug use in Malawian children under five years old, Trans R Soc Trop Med Hyg 90 [1], Seite 66-8. URL:

Nwanyanwu, O. C.; Ziba, C.; MacHeso, A. und Kazembe, P. (2000): Efficacy of sulphadoxine-pyrimethamine for acute uncomplicated malaria due to Plasmodium falciparum in Malawian children under five years old, Trop Med Int Health 5 [5], Seite 355-8. URL:

Nzila-Mounda, A.; Mberu, E. K.; Sibley, C. H.; Plowe, C. V.; Winstanley, P. A. und Watkins, W. M. (1998): Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain, Antimicrob Agents Chemother 42 [1], Seite 164-9. URL:

Nzila, A. M.; Mberu, E. K.; Sulo, J.; Dayo, H.; Winstanley, P. A.; Sibley, C. H. und Watkins, W. M. (2000): Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites, Antimicrob Agents Chemother 44 [4], Seite 991-6. URL:

Ofori-Adjei, D.; Ajepon-Yamoah, K.K.; Commey, J.O.O. und Ofori-Adjei, E. (1988): In vivo sensitivity of P. falciparum to chloroquine in Accra, Ghana, Ghana Medical Journal 22, Seite 11-14.

Olivar, M.; Develoux, M.; Chegou Abari, A. und Loutan, L. (1991): Presumptive diagnosis of malaria results in a significant risk of mistreatment of children in urban Sahel, Trans R Soc Trop Med Hyg 85 [6], Seite 729-30. URL:

Olliaro, P.; Cattani, J. und Wirth, D. (1996): Malaria, the submerged disease, Jama 275 [3], Seite 230-3. URL:

Olliaro, P. L. und Trigg, P. I. (1995): Status of antimalarial drugs under development, Bull World Health Organ 73 [5], Seite 565-71. URL:

Olliaro, P.; Nevill, C.; LeBras, J.; Ringwald, P.; Mussano, P.; Garner, P. und Brasseur, P. (1996): Systematic review of amodiaquine treatment in uncomplicated malaria, Lancet 348 [9036], Seite 1196-201. URL:

Pasvol, G.; Weatherall, D. J. und Wilson, R. J. (1977): Effects of foetal haemoglobin on susceptibility of red cells to Plasmodium falciparum, Nature 270 [5633], Seite 171-3. URL:

Paul, R. E.; Hackford, I.; Brockman, A.; Muller-Graf, C.; Price, R.; Luxemburger, C.; White, N. J.; Nosten, F. und Day, K. P. (1998): Transmission intensity and Plasmodium falciparum diversity on the northwestern border of Thailand, Am J Trop Med Hyg 58 [2], Seite 195-203. URL:

Paul, R. E.; Packer, M. J.; Walmsley, M.; Lagog, M.; Ranford-Cartwright, L. C.; Paru, R. und Day, K. P. (1995): Mating patterns in malaria parasite populations of Papua New Guinea, Science 269 [5231], Seite 1709-11. URL:

Peters, W.; Robinson, B. L. und Ellis, D. S. (1987): The chemotherapy of rodent malaria. XLII. Halofantrine and halofantrine resistance, Ann Trop Med Parasitol 81 [5], Seite 639-46. URL:

Phillips-Howard, P. A. und West, L. J. (1990): Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain, J R Soc Med 83 [2], Seite 82-5. URL:

Pinichpongse, S.; Doberstyn, E. B.; Cullen, J. R.; Yisunsri, L.; Thongsombun, Y. und Thimasarn, K. (1982): An evaluation of five regimens for the outpatient therapy of falciparum malaria in Thailand 1980-81, Bull World Health Organ 60 [6], Seite 907-12. URL:

Plowe, C. V.; Djimde, A.; Wellems, T. E.; Diop, S.; Kouriba, B. und Doumbo, O. K. (1996): Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance, Am J Trop Med Hyg 55 [5], Seite 467-71. URL:

Price, R. N. und Nosten, F. (2001): Drug resistant falciparum malaria: clinical consequences and strategies for prevention, Drug Resist Updat 4 [3], Seite 187-96. URL:

Price, R. N.; Nosten, F.; Luxemburger, C.; ter Kuile, F. O.; Paiphun, L.; Chongsuphajaisiddhi, T. und White, N. J. (1996): Effects of artemisinin derivatives on malaria transmissibility, Lancet 347 [9016], Seite 1654-8. URL:

Qinghaosu, Coordinating Research on the Structure of (1977): Coordinating Research on the Structure of Qinghaosu, Kexue Tongbao 22, Seite 142.

Rahman, M.; Rahman, R.; Bangali, M.; Das, S.; Talukder, M. R. und Ringwald, P. (2004): Efficacy of combined chloroquine and sulfadoxine-pyrimethamine in uncomplicated Plasmodium falciparum malaria in Bangladesh, Trans R Soc Trop Med Hyg 98 [7], Seite 438-41. URL:

Ranford-Cartwright, L. C.; Taylor, J.; Umasunthar, T.; Taylor, L. H.; Babiker, H. A.; Lell, B.; Schmidt-Ott, J. R.; Lehman, L. G.; Walliker, D. und Kremsner, P. G. (1997): Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon, Trans R Soc Trop Med Hyg 91 [6], Seite 719-24. URL:

Reilley, B.; Abeyasinghe, R. und Pakianathar, M. V. (2002): Barriers to prompt and effective treatment of malaria in northern Sri Lanka, Trop Med Int Health 7 [9], Seite 744-9. URL:

Rieckmann, K.; Suebsaeng, L. und Rooney, W. (1987): Response of Plasmodium falciparum infections to pyrimethamine-sulfadoxine in Thailand, Am J Trop Med Hyg 37 [2], Seite 211-6. URL:

Ringwald, P. und Basco, L. K. (1998): Malarone-donation programme in Africa, Lancet 351 [9103], Seite 673-4. URL:

Ronn, A. M.; Msangeni, H. A.; Mhina, J.; Wernsdorfer, W. H. und Bygbjerg, I. C. (1996): High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania, Trans R Soc Trop Med Hyg 90 [2], Seite 179-81. URL:

Rwagacondo, C. E.; Niyitegeka, F.; Sarushi, J.; Karema, C.; Mugisha, V.; Dujardin, J. C.; Van Overmeir, C.; van den Ende, J. und D'Alessandro, U. (2003): Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate, Am J Trop Med Hyg 68 [6], Seite 743-7. URL:

Sachs, J. und Malaney, P. (2002): The economic and social burden of malaria, Nature 415 [6872], Seite 680-5. URL:

Schapira, A.; Beales, P. F. und Halloran, M. E. (1993): Malaria: Living with drug resistance, Parasitol Today 9 [5], Seite 168-74. URL:

Shretta, R.; Omumbo, J.; Rapuoda, B. und Snow, R. W. (2000): Using evidence to change antimalarial drug policy in Kenya, Trop Med Int Health 5 [11], Seite 755-64. URL:

Smithells, R. W. und Sheppard, S. (1983): Teratogenicity of debendox and pyrimethamine, Lancet 2 [8350], Seite 623-4. URL:

Snow, R. W.; Bastos de Azevedo, I.; Lowe, B. S.; Kabiru, E. W.; Nevill, C. G.; Mwankusye, S.; Kassiga, G.; Marsh, K. und Teuscher, T. (1994): Severe childhood malaria in two areas of markedly different falciparum transmission in east Africa, Acta Trop 57 [4], Seite 289-300. URL:

Snow, R. W.; Craig, M.; Deichmann, U. und Marsh, K. (1999): Estimating mortality, morbidity and disability due to malaria among Africa´s non-pregnant population, Bull World Health Organ 77, Seite 624-640.

Snow, R. W.; Peshu, N.; Forster, D.; Mwenesi, H. und Marsh, K. (1992): The role of shops in the treatment and prevention of childhood malaria on the coast of Kenya, Trans R Soc Trop Med Hyg 86 [3], Seite 237-9. URL:

Sowunmi, A. (2002): A randomized comparison of chloroquine, amodiaquine and their combination with pyrimethamine-sulfadoxine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children, Ann Trop Med Parasitol 96 [3], Seite 227-38. URL:

Sowunmi, A. und Akindele, J. A. (1993): Presumptive diagnosis of malaria in infants in an endemic area, Trans R Soc Trop Med Hyg 87 [4], Seite 422. URL: ://

Staedke, S. G.; Kamya, M. R.; Dorsey, G.; Gasasira, A.; Ndeezi, G.; Charlebois, E. D. und Rosenthal, P. J. (2001): Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial, Lancet 358 [9279], Seite 368-74. URL:

Strickland, G. T.; Fox, E. und Hadi, H. (1988): Malaria and splenomegaly in the Punjab, Trans R Soc Trop Med Hyg 82 [5], Seite 667-70. URL:

Sturchler, D.; Mittelholzer, M. L. und Kerr, L. (1993): How frequent are notified severe cutaneous adverse reactions to Fansidar ?, Drug Saf 8 [2], Seite 160-8. URL:

Sutherland, C. J.; Alloueche, A.; Curtis, J.; Drakeley, C. J.; Ord, R.; Duraisingh, M.; Greenwood, B. M.; Pinder, M.; Warhurst, D. und Targett, G. A. (2002): Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes, Am J Trop Med Hyg 67 [6], Seite 578-85. URL:

Talisuna, A. O.; Nalunkuma-Kazibwe, A.; Bakyaita, N.; Langi, P.; Mutabingwa, T. K.; Watkins, W. W.; Van Marck, E.; D'Alessandro, U. und Egwang, T. G. (2004): Efficacy of sulphadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan children, Trop Med Int Health 9 [2], Seite 222-9. URL:

Teklehaimanot, A. und Snow, R. W. (2002): Will the Global Fund help roll back malaria in Africa ?, Lancet 360 [9337], Seite 888-9. URL:

Trape, J. F. (2001): The public health impact of chloroquine resistance in Africa, Am J Trop Med Hyg 64 [1-2 Suppl], Seite 12-7. URL:

Trape, J. F.; Pison, G.; Preziosi, M. P.; Enel, C.; Desgrees du Lou, A.; Delaunay, V.; Samb, B.; Lagarde, E.; Molez, J. F. und Simondon, F. (1998): Impact of chloroquine resistance on malaria mortality, C R Acad Sci III 321 [8], Seite 689-97 URL:

van Dillen, J.; Custers, M.; Wensink, A.; Wouters, B.; van Voorthuizen, T.; Voorn, W.; Khan, B.; Muller, L. und Nevill, C. (1999): A comparison of amodiaquine and sulfadoxine-pyrimethamine as first-line treatment of falciparum malaria in Kenya, Trans R Soc Trop Med Hyg 93 [2], Seite 185-8. URL:

van Hensbroek, M. B.; Morris-Jones, S.; Meisner, S.; Jaffar, S.; Bayo, L.; Dackour, R.; Phillips, C. und Greenwood, B. M. (1995): Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria, Trans R Soc Trop Med Hyg 89 [6], Seite 672-6. URL:

Verdrager, J. (1986): Epidemiology of the emergence and spread of drug-resistant falciparum malaria in South-East Asia and Australasia, J Trop Med Hyg 89 [6], Seite 277-89. URL:

Verdrager, J.; Riche, A. und Chheang, C. M. (1967): [Treatment of "P. falciparum" malaria by delayed-action sulfonamides], Presse Med 75 [55], Seite 2839-40. URL:

Verhoeff, F. H.; Brabin, B. J.; Masache, P.; Kachale, B.; Kazembe, P. und Van der Kaay, H. J. (1997): Parasitological and haematological responses to treatment of Plasmodium falciparum malaria with sulphadoxine-pyrimethamine in southern Malawi, Ann Trop Med Parasitol 91 [2], Seite 133-40. URL:

von Seidlein, L.; Bojang, K.; Jones, P.; Jaffar, S.; Pinder, M.; Obaro, S.; Doherty, T.; Haywood, M.; Snounou, G.; Gemperli, B.; Gathmann, I.; Royce, C.; McAdam, K. und Greenwood, B. (1998): A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children, Am J Trop Med Hyg 58 [5], Seite 638-44. URL:

von Seidlein, L.; Jawara, M.; Coleman, R.; Doherty, T.; Walraven, G. und Targett, G. (2001): Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria, Trop Med Int Health 6 [2], Seite 92-8. URL:

Wang, P.; Lee, C. S.; Bayoumi, R.; Djimde, A.; Doumbo, O.; Swedberg, G.; Dao, L. D.; Mshinda, H.; Tanner, M.; Watkins, W. M.; Sims, P. F. und Hyde, J. E. (1997): Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins, Mol Biochem Parasitol 89 [2], Seite 161-77. URL:

Ward, S. A. (1988): Mechanisms of chloroquine resistance in malarial chemotherapy, Trends Pharmacol Sci 9 [7], Seite 241-6. URL:

Watkins, W. M. und Mosobo, M. (1993): Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life, Trans R Soc Trop Med Hyg 87 [1], Seite 75-8. URL:

Webster, H. K.; Boudreau, E. F.; Pavanand, K.; Yongvanitchit, K. und Pang, L. W. (1985): Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method, Am J Trop Med Hyg 34 [2], Seite 228-35. URL:

Wellems, T. E. und Plowe, C. V. (2001): Chloroquine-resistant malaria, J Infect Dis 184 [6], Seite 770-6. URL:

Wernsdorfer, W. H. (1991): The development and spread of drug-resistant malaria, Parasitol Today 7 [11], Seite 297-303. URL:

Wernsdorfer, W. H. (1994): Epidemiology of drug resistance in malaria, Acta Trop 56 [2-3], Seite 143-56. URL:

Wernsdorfer, W. H. und Payne, D. (1991): The dynamics of drug resistance in Plasmodium falciparum, Pharmacol Ther 50 [1], Seite 95-121. URL:

Wetsteyn, J. C.; De Vries, P. J.; Oosterhuis, B. und Van Boxtel, C. J . (1995): The pharmacokinetics of three multiple dose regimens of chloroquine: implications for malaria chemoprophylaxis, Br J Clin Pharmacol 39 [6], Seite 696-9. URL:

White, N. J. (1992): Antimalarial drug resistance: the pace quickens, J Antimicrob Chemother 30 [5], Seite 571-85. URL:

White, N. J. (1996): Can amodiaquine be resurrected ?, Lancet 348 [9036], Seite 1184-5. URL:

White, N. J. (1996): Malaria, Cook, G. C., Manson´s Tropical Diseases Seite 1087-1165, WB Saunders Company Ltd, London.

White, N. J. (1998): Why is it that antimalarial drug treatments do not always work ?, Annals of Tropical Medicine and Parasitology 92, Seite 449-458.

White, N. J. (2002): The assessment of antimalarial drug efficacy, Trends Parasitol 18 [10], Seite 458-64. URL:

White, N. J. und Krishna, S. (1989): Treatment of malaria: some considerations and limitations of the current methods of assessment, Trans R Soc Trop Med Hyg 83 [6], Seite 767-77. URL:

White, N. J.; Nosten, F.; Looareesuwan, S.; Watkins, W. M.; Marsh, K.; Snow, R. W.; Kokwaro, G.; Ouma, J.; Hien, T. T.; Molyneux, M. E.; Taylor, T. E.; Newbold, C. I.; Ruebush, T. K., 2nd; Danis, M.; Greenwood, B. M.; Anderson, R. M. und Olliaro, P. (1999): Averting a malaria disaster, Lancet 353 [9168], Seite 1965-7. URL:

WHO (1973): Chemotherapy of malaria and resistance to antimalarials. Report of a WHO scientific group, World Health Organ Tech Rep Ser 529 , Seite 1-121. URL:

WHO (1990): Practical chemotherapy of malaria. Report of a WHO Scientific Group, World Health Organ Tech Rep Ser 805, Seite 1-141. URL:

WHO (1994): Antimalarial drug policies: data requirements, treatment of uncomplicated malaria, and management of malaria in pregnancy, Geneva, World Health Organisation, WHO/MAL/94.1070

WHO (1996): Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission

Geneva, World Health Organisation, WHO/MAL/96.1077

WHO (1997): World malaria situation in 1994 Wkly Epidemiol Rec 72 [36-38], Seite 269-92. URL:

WHO (2000): Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster, Trans R Soc Trop Med Hyg 94 Suppl 1, Seite S1-90. URL:

WHO (2001): Antimalarial drug combination therapy-Report of a WHO Technical Consultation, Geneva, World Health Organisation,

WHO (2002): Monitoring Antimalarial Drug Resistance, Geneva, World Health Organisation WHO/CDS/CSR/EPH/2002.17.

Wongsrichanalai, C.; Pickard, A. L.; Wernsdorfer, W. H. und Meshnick, S. R. (2002): Epidemiology of drug-resistant malaria, Lancet Infect Dis 2 [4], Seite 209-18. URL:

Zucker, J. R.; Lackritz, E. M.; Ruebush, T. K., 2nd; Hightower, A. W.; Adungosi, J. E.; Were, J. B.; Metchock, B.; Patrick, E. und Campbell, C. C . (1996): Childhood mortality during and after hospitalization in western Kenya: effect of malaria treatment regimens, Am J Trop Med Hyg 55 [6], Seite 655-60. URL:

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: